{"id":"W2294633761","doi":"10.1093/annonc/mdw133","title":"Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"Myriad Genetics; AstraZeneca","keywords":"Olaparib; Medicine; Internal medicine; Ovarian cancer; Oncology; PARP inhibitor; Population; BRCA mutation; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004684954,0.0001211453,0.0006585892,0.0003866107,0.00002367284,0.00000187154,0.0000382073,0.00009398779,0.0001023768],"category_scores_gemma":[0.0001221969,0.00008236214,0.000042996,0.0005152246,0.0002408778,0.00008585193,0.00001330636,0.00006672354,2.838672e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006744774,"about_ca_system_score_gemma":0.0001689668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001583905,"about_ca_topic_score_gemma":0.0003948513,"domain_scores_codex":[0.9987764,0.0002023151,0.0004617682,0.000259309,0.0001471575,0.0001530694],"domain_scores_gemma":[0.9985214,0.0005436644,0.0003328713,0.0001894369,0.0003402663,0.00007230949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1251901,0.000829696,0.6876582,0.00003427729,0.001437746,0.00002161845,0.00247802,0.0000703948,0.01425198,0.00006006682,0.0000804912,0.1678874],"study_design_scores_gemma":[0.03074266,0.00487998,0.9578866,0.0001552572,0.0001747688,0.000002572644,0.00007722479,0.0000709407,0.004573631,0.00006163058,0.001280587,0.00009417324],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923383,0.0006533529,0.0001736422,0.006187273,0.00002704519,0.0004481071,0.0001118794,0.000008639471,0.00005173351],"genre_scores_gemma":[0.99672,0.001383746,0.0009382768,0.0007789257,0.00001176385,0.00006461451,0.00001322193,0.0000129888,0.00007647037],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2702284,"threshold_uncertainty_score":0.3358631,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03294610948529814,"score_gpt":0.3865217980239725,"score_spread":0.3535756885386743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}